Request a copy

Full Text

Full Text Parts

• Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., and Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol. 2 (2000) 737-744
• Blacher S., Devy L., Burbridge M.F., Roland G., Tucker G., Noel A., and Foidart J.M. Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4 (2001) 133-142
• Blacher S., Devy L., Hlushchuk R., Larger E., Lamandé N., Burri P., Corvol P., Djonov V.G., Foidart J.M., and Noel A. Quantification of angiogenesis in the chicken chorioallantoic membrane (CAM). Image Anal. Stereol. 24 (2005) 169-180
• Blacher S., Jost M., Melen-Lamalle L., Lund L.R., Romer J., Foidart J.M., and Noel A. Quantification of in vivo tumor invasion and vascularization by computerized image analysis. Microvasc. Res. 75 (2008) 169-178
• Bock F., Onderka J., Dietrich T., Bachmann B., Kruse F.E., Paschke M., Zahn G., and Cursiefen C. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Ophthalmol. Vis. Sci. 48 (2007) 2545-2552
• Bock F., Onderka J., Hos D., Horn F., Martus P., and Cursiefen C. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp. Eye Res. 87 5 (2008) 462-470
• Bruyere F., Melen-Lamalle L., Blacher S., Roland G., Thiry M., Moons L., Frankenne F., Carmeliet P., Alitalo K., Libert C., Sleeman J.P., Foidart J.M., and Noel A. Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 5 (2008) 431-437
• Hiraoka N., Allen E., Apel I.J., Gyetko M.R., and Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95 (1998) 365-377
• Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., and Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58 (1998) 1048-1051
• Kapur J.N., Sahoo P.K., and Wong A.K.C. A new method for gray-level picture thresholding using the entropy of the histogram. Comput. Vision Graph. Image Process. 29 (1985) 273-285
• Kato T., Kure T., Chang J.H., Gabison E.E., Itoh T., Itohara S., and Azar D.T. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508 (2001) 187-190
• Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noel A., and Rakic J.M. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 17 (2003) 2290-2292
• Maquoi E., Sounni N.E., Devy L., Olivier F., Frankenne F., Krell H.W., Grams F., Foidart J.M., and Noel A. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clin. Cancer Res. 10 (2004) 4038-4047
• Masson V., de la Ballina L.R., Munaut C., Wielockx B., Jost M., Maillard C., Blacher S., Bajou K., Itoh T., Itohara S., Werb Z., Libert C., Foidart J.M., and Noel A. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J. 19 (2005) 234-236
• Noel A., Jost M., Lambert V., Lecomte J., and Rakic J.M. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends Mol. Med. 13 (2007) 345-352
• Noel A., Jost M., and Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin. Cell Dev. Biol. 19 (2008) 52-60
• Rutkowski J.M., Boardman K.C., and Swartz M.A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1402-1410
• Soille P. Morphological image analysis (1999), Springer-Verlag, Berlin, Heidelberg, New York